Ionis Pharmaceuticals Stock Profit Margin
| IONS Stock | USD 33.94 1.46 4.12% |
Ionis Pharmaceuticals fundamentals help investors to digest information that contributes to Ionis Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Ionis Stock. The fundamental analysis module provides a way to measure Ionis Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ionis Pharmaceuticals stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (0.47) | (0.49) |
Ionis | Profit Margin |
Ionis Pharmaceuticals Company Profit Margin Analysis
Ionis Pharmaceuticals' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Ionis Pharmaceuticals Profit Margin | (0.45) % |
Most of Ionis Pharmaceuticals' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ionis Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ionis Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Ionis Pharmaceuticals is extremely important. It helps to project a fair market value of Ionis Stock properly, considering its historical fundamentals such as Profit Margin. Since Ionis Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ionis Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ionis Pharmaceuticals' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Ionis Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Ionis Pharmaceuticals has a Profit Margin of -0.4468%. This is 96.01% lower than that of the Biotechnology sector and 98.06% lower than that of the Health Care industry. The profit margin for all United States stocks is 64.82% lower than that of the firm.
Ionis Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ionis Pharmaceuticals' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ionis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ionis Pharmaceuticals by comparing valuation metrics of similar companies.Ionis Pharmaceuticals is currently under evaluation in profit margin category among its peers.
Ionis Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ionis Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ionis Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Ionis Fundamentals
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.0725 | ||||
| Profit Margin | (0.45) % | ||||
| Operating Margin | (1.11) % | ||||
| Current Valuation | 4.32 B | ||||
| Shares Outstanding | 157.9 M | ||||
| Shares Owned By Insiders | 0.76 % | ||||
| Shares Owned By Institutions | 99.24 % | ||||
| Number Of Shares Shorted | 10.74 M | ||||
| Price To Earning | 101.16 X | ||||
| Price To Book | 8.09 X | ||||
| Price To Sales | 6.67 X | ||||
| Revenue | 787.65 M | ||||
| Gross Profit | (257.87 M) | ||||
| EBITDA | (230.01 M) | ||||
| Net Income | (366.29 M) | ||||
| Cash And Equivalents | 2.04 B | ||||
| Cash Per Share | 14.36 X | ||||
| Total Debt | 1.45 B | ||||
| Debt To Equity | 2.00 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 4.20 X | ||||
| Cash Flow From Operations | (307.51 M) | ||||
| Short Ratio | 7.97 X | ||||
| Earnings Per Share | (2.44) X | ||||
| Price To Earnings To Growth | 25.70 X | ||||
| Target Price | 61.36 | ||||
| Number Of Employees | 927 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 5.36 B | ||||
| Total Asset | 2.99 B | ||||
| Retained Earnings | (1.8 B) | ||||
| Working Capital | 2.19 B | ||||
| Current Asset | 837 M | ||||
| Current Liabilities | 148.88 M | ||||
| Net Asset | 2.99 B |
About Ionis Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ionis Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ionis Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ionis Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.